Innovation in bone healing and tissue repair

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies.

Areas of interest are:

Kuros is seeking to maximise value from its development programs and proprietary localized delivery technology. To achieve this Kuros is interested in:

  • Relationships with commercialization partners for its lead product candidates
  • Collaboration or partnership with entities around its technologies and/or specific product candidates

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies. Kuros has a flexible approach to deal structuring and aims to create relationships that maximize the value for both parties.

Please direct any inquiries to:

Alistair Irvine, PhD
Chief Business Officer
Tel: +41 44 200 5647

Email: bd@kuros.ch

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kuros.ch

About Kuros

  1. Overview
  2. Management
  3. Board

Products

  1. Pipeline
  2. Orthobiologics
    Fracture repair
    KUR-111
    KUR-113
    MagnetOs
    Spinal fusion
    KUR-113
    MagnetOs
    Solitary Bone Cysts
    KUR-112
  3. Sealants
    Neuroseal (KUR-023)

Technologies

  1. Overview
  2. Surface Science Technology
  3. Synthetic Cross-Linking Technology
  4. Fibrin-Based
  5. Immune Modulation
  6. Publications

Partnerships

  1. Collaborations
  2. Business development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Business development

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies.

Areas of interest are:

Kuros is seeking to maximise value from its development programs and proprietary localized delivery technology. To achieve this Kuros is interested in:

  • Relationships with commercialization partners for its lead product candidates
  • Collaboration or partnership with entities around its technologies and/or specific product candidates

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies. Kuros has a flexible approach to deal structuring and aims to create relationships that maximize the value for both parties.

Please direct any inquiries to:

Alistair Irvine, PhD
Chief Business Officer
Tel: +41 44 200 5647

Email: bd@kuros.ch